SLC2A1 and cancer: Glucose transporter type 1 (Glut1) expression was reported to be upregulated in 5-FU resistant cancer cells, and exogenous overexpression of Glut1 facilitated colorectal cancer cells obtaining resistance to 5-FU [14].